Abiomed (ABMD) Announces FDA PMA Approval for Impella RP for Right Heart Failure
Tweet Send to a Friend
Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced it has received U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE